BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as ...

KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce ...

The tech firm will prioritize Ethereum over Bitcoin as a strategic asset, touting the asset's potential as a "financial ...

KUALA LUMPUR - BioNexus Gene Lab Corp. (NASDAQ: BGLC), a Nasdaq-listed technology company in the healthcare sector with a market capitalization of $5.88 million and annual revenue of $9.26 million ...

KUALA LUMPUR – BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $6.83 million and a current stock price of $0.37, has made significant ...

KUALA LUMPUR – BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $6.83 million and a current stock price of $0.37, has made significant ...

BioNexus Gene Lab Corporation, a Nasdaq-listed company, has unveiled an Ethereum-focused treasury strategy, emphasizing ...

Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other ...